Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients
Alexandra Ioana Moatăr, Aimée Rodica Chiş, Mirabela Romanescu, Paula-Diana Ciordas, Diana Nițușcă, Cătălin Marian, Cristian Oancea, Ioan Ovidiu Sîrbu
Abstract
Predicting the clinical course of Covid-19 is a challenging task, given the multi-systemic character of the disease and the paucity of minimally invasive biomarkers of disease severity. Here, we evaluated the early (first two days post-admission) level of circulating hsa-miR-195-5p (miR-195, a known responder to viral infections and SARS-CoV-2 interactor) in Covid-19 patients and assessed its potential as a biomarker of disease severity. We show that plasma miR-195 correlates with several clinical and paraclinical parameters, and is an excellent discriminator between the severe and mild forms of the disease. Our Gene Ontology analysis of miR-195 targets differentially expressed in Covid-19 indicates a strong impact on cardiac mitochondria homeostasis, suggesting a possible role in long Covid and chronic fatigue syndrome (CFS) syndromes.